Efficacy of Citalopram in Improving Depression and Quality of Life in Acute Coronary Syndrome
Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Background and
Purpose
Prevalence of depression in patients with acute coronary syndrome (ACS) is reported to be 10-40%. Post-ACS depression is associated with higher mortality and morbidity in patients, therefore, it requires more attention.
Materials And Methods
In a clinical trial (conducted in Babol University of Medical Sciences, 2015-2016), 47 hospitalized patients with ACS diagnosis were randomly allocated into two groups. Twenty-four patients in intervention group received 20 mg/day citalopram and 23 individuals in the control group were followed without receiving citalopram. Hospital anxiety and depression scale (HADS) was applied at weeks 0, 3, and 8. The participants’ quality of life was evaluated at weeks 0 and 8. Seven patients were excluded from the study since they did not return for follow-up.
Results
A total of 40 patients was studied including 14 (35%) males and 26 (65%) females. Mean ages of patients in in intervention group and controls were 63.1±8.8 and 68.4±7.9 years, respectively. Depression and anxiety levels reduced significantly in intervention group and their quality of life increased in week 8 (P
Conclusion
Citalopram could be effective in reducing depression and improving quality of life in acute coronary syndrome.
Language:
Persian
Published:
Journal of Mazandaran University of Medical Sciences, Volume:27 Issue: 158, 2018
Pages:
67 to 77
magiran.com/p1803591  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 990,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 50 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!